TP53 and neoplasm: p53−/− mice had obviously larger tumours than did p53+/+ mice, and ASNase supplementation reduced tumour growth and abolished the difference in both tumour sizes and plasma asparagine levels between p53+/+ and p53−/− mice (Supplementary Fig. 1f–h).